Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CDK5 inhibitor 20-223, a potent inhibitor of CDK2 and CDK5, demonstrates IC50 values of 6.0 nM and 8.8 nM, respectively. It serves as an effective agent against colorectal cancer (CRC)[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 95.00 | |
50 mg | 6-8 weeks | $ 789.00 | |
100 mg | 6-8 weeks | $ 1,180.00 |
Description | CDK5 inhibitor 20-223, a potent inhibitor of CDK2 and CDK5, demonstrates IC50 values of 6.0 nM and 8.8 nM, respectively. It serves as an effective agent against colorectal cancer (CRC)[1]. |
Targets&IC50 | CDK2:6.0 nM (IC50), CDK5:8.8 nM (IC50) |
In vitro | CDK5 inhibitor 20-223 (10 nM-10 μM; 72 hours) potently inhibits cell growth in a panel of colorectal cancer (CRC) cell lines[1].CDK5 inhibitor 20-223 (0.3125-20 μM; 6 hours) induces a dose-dependent decrease in pRB (S807/811) and pFAK (S732) levels in each of the three CRC cell lines[1]. Cell Viability Assay[1] Cell Line: CRC cell lines SW620, DLD1, HT29, HCT116, FET, CBS, and GEO cells |
In vivo | CDK5 inhibitor 20-223 (8mg/kg; subcutaneously; for 14 injections) shows anti-tumor activity in human CRC xenograft tumors in nude mice[1]. Animal Model: Athymic nude mice[1] |
Synonyms | CDK5 inhibitor 20-223 |
Molecular Weight | 305.37 |
Formula | C19H19N3O |
CAS No. | 865317-30-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CDK5 inhibitor 20-223 865317-30-2 CDK5 inhibitor 20223 CDK5 inhibitor 20 223 CDK-5 inhibitor 20-223 inhibitor inhibit